RAPID: A Lung Mucus Strategy for COVID-19 Viral Protection
RAPID:针对 COVID-19 病毒防护的肺粘液策略
基本信息
- 批准号:2028758
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Vulnerability to COVID-19 arises from multiple risk factors, but two are particularly prominent: lack of antibodies (Ab) to the novel coronavirus; and structural properties of lung mucus. This project addresses both risk factors through focused experiments and data from two labs in an active feedback loop with mathematical modeling, simulations, and theory. The mathematical effort will provide a platform, starting from a baseline model and simulation of exposure to inhaled COVID-19 without Ab protection. The baseline model will distinguish clearance of the inhaled viral load versus onset and propagation of respiratory infection. Two experimental interventions will be simulated on top of the baseline model at progressive stages of infection: inhaled doses of COVID-19-specific monoclonal antibodies (mAb) and of structure-targeted mucolytics. Both labs will leverage mathematical predictions to accelerate and optimize their strategies to mitigate COVID-19 disease. Likewise, experimental results and data will be leveraged to validate models and learn hidden factors critical to the predictive accuracy of the models. The potential broader impact of this project is to predict optimal, mAb-based and mucolytic-based treatments for specific sub-populations at various stages of COVID-19 lung infection.The mathematical modeling platform will explore the delicate interplay among: inhaled loads of COVID-19, their diffusion within, and potentially through, the mucus-coated respiratory tract; infectivity onset as COVID-19 reaches and invades epithelial cells, produces daughters that invade new cells and propagate the infection; how long after exposure to COVID-19 either natural antibodies or engineered mAb are introduced into the mucus layer; and, the rate of clearance of the mucus layer from the lung. The latter clearance rate is known to depend, often dramatically, on structural properties of mucus in vulnerable sub-populations to COVID-19. The experimental team will test outcomes of existing mAb on non-infectious COVID-19 nanoparticles. A multi-species stochastic model will simulate diffusion and propagation of COVID-19, interrupted by mAb-crosslinks between COVID-19 and mucins. Some reaction-diffusion parameters are measured while others will be learned from experimental data using hidden Markov methods. A polymer-physics-based molecular dynamics model of mucus will simulate structure properties of mucus based on the chemical structure and concentrations of mucin polymers known for specific sub-populations. With this modeling platform, the goals are to: optimize mAb design; characterize efficiency of given mAb affinities to COVID-19 and mucus; and quantify the inhaled mAb dose required to arrest COVID-19 infection at various stages of progression, specific to mucus structure properties.This grant is being awarded using funds made available by the Coronavirus Aid, Relief, and Economic Security (CARES) Act supplemental funds allocated to MPS.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
对COVID-19的脆弱性由多种风险因素引起,但有两个风险因素尤为突出:缺乏针对新型冠状病毒的抗体(Ab);以及肺粘液的结构特性。该项目通过重点实验和两个实验室的数据,通过数学建模、模拟和理论,在一个主动反馈回路中解决这两个风险因素。这项数学工作将提供一个平台,从基线模型开始,模拟在没有抗体保护的情况下吸入COVID-19的暴露。基线模型将区分吸入病毒载量的清除与呼吸道感染的发病和传播。在感染进展阶段的基线模型基础上,将模拟两种实验性干预措施:吸入剂量的covid -19特异性单克隆抗体(mAb)和结构靶向黏液解药。这两个实验室将利用数学预测来加速和优化其缓解COVID-19疾病的策略。同样,将利用实验结果和数据来验证模型,并了解对模型预测准确性至关重要的隐藏因素。该项目潜在的更广泛影响是预测针对COVID-19肺部感染不同阶段的特定亚群的最佳、基于单克隆抗体和基于黏液溶解剂的治疗方法。该数学建模平台将探索以下因素之间的微妙相互作用:吸入的COVID-19负荷,它们在粘液覆盖的呼吸道内和可能通过呼吸道的扩散;随着COVID-19到达并侵入上皮细胞,产生子代侵入新细胞并传播感染,传染性开始发作;暴露于COVID-19后多久,天然抗体或工程单克隆抗体被引入黏液层;以及肺部黏液层的清除率。众所周知,后一种清除率通常在很大程度上取决于COVID-19易感亚群中黏液的结构特性。实验小组将测试现有的单抗对非传染性COVID-19纳米颗粒的效果。一个多物种随机模型将模拟COVID-19的扩散和传播,并被COVID-19与粘蛋白之间的单克隆抗体交联所中断。一些反应扩散参数是测量的,而其他的将使用隐马尔可夫方法从实验数据中学习。基于聚合物物理的黏液分子动力学模型将基于特定亚群已知的黏液聚合物的化学结构和浓度来模拟黏液的结构特性。利用该建模平台,目标是:优化mAb设计;表征给定单抗对COVID-19和黏液的亲和力;并量化在不同进展阶段阻止COVID-19感染所需的吸入单抗剂量,具体到粘液结构特性。这笔拨款是使用《冠状病毒援助、救济和经济安全(关怀)法案》分配给MPS的补充资金提供的资金。该奖项反映了美国国家科学基金会的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19.
- DOI:10.1016/j.jconrel.2020.11.057
- 发表时间:2021-01-10
- 期刊:
- 影响因子:0
- 作者:Lai SK;McSweeney MD;Pickles RJ
- 通讯作者:Pickles RJ
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy.
- DOI:10.1016/j.addr.2020.12.004
- 发表时间:2021-03
- 期刊:
- 影响因子:16.1
- 作者:Cruz-Teran C;Tiruthani K;McSweeney M;Ma A;Pickles R;Lai SK
- 通讯作者:Lai SK
Chain stiffness boosts active nanoparticle transport in polymer networks
链刚度促进聚合物网络中活性纳米粒子的传输
- DOI:10.1103/physreve.103.052501
- 发表时间:2021
- 期刊:
- 影响因子:2.4
- 作者:Cao, Xue-Zheng;Merlitz, Holger;Wu, Chen-Xu;Forest, M. Gregory
- 通讯作者:Forest, M. Gregory
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M Forest其他文献
Testicular response to hCG in the immature lamb
未成熟羔羊对人绒毛膜促性腺激素的睾丸反应
- DOI:
10.1203/00006450-198101000-00060 - 发表时间:
1981-01-01 - 期刊:
- 影响因子:3.100
- 作者:
J R Ducharme;R Hamel;C Polychronakos;M Forest;F Haour;G Charpenet;W Gibb;R Collu - 通讯作者:
R Collu
M Forest的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M Forest', 18)}}的其他基金
Statistical and Applied Mathematical Sciences Institute
统计与应用数学科学研究所
- 批准号:
1929298 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
Collaborative Research: Computational Modeling of How Living Cells Utilize Liquid-Liquid Phase Separation to Organize Chemical Compartments
合作研究:活细胞如何利用液-液相分离来组织化学区室的计算模型
- 批准号:
1816630 - 财政年份:2018
- 资助金额:
$ 20万 - 项目类别:
Continuing Grant
Statistical and Applied Mathematical Sciences Institute
统计与应用数学科学研究所
- 批准号:
1638521 - 财政年份:2017
- 资助金额:
$ 20万 - 项目类别:
Continuing Grant
Collaborative Research: Kinetic to Continuum Modeling of Active Anisotropic Fluids
合作研究:活性各向异性流体的动力学到连续体建模
- 批准号:
1517274 - 财政年份:2015
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
A Mathematical-Experimental Strategy to Discern the Molecular Basis of "Successful Mucus"
辨别“成功粘液”分子基础的数学实验策略
- 批准号:
1462992 - 财政年份:2015
- 资助金额:
$ 20万 - 项目类别:
Continuing Grant
Collaborative Research: A Molecular-to-Continuum, Data-Driven Strategy for Mucus Transport Modeling
协作研究:粘液运输建模的分子到连续体、数据驱动策略
- 批准号:
1412844 - 财政年份:2014
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
Collaborative Research on Mathematical Constructs for Multiphase Complex Fluids
多相复杂流体数学结构的合作研究
- 批准号:
0908423 - 财政年份:2009
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
Collaborative Research: Collaborative Proposal for Mathematics & Computation of Nano-Composite Flows & Properties
合作研究:数学合作提案
- 批准号:
0604891 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
Multi-scale Phenomena in Macromolecular Fluids and Nano-Composite Materials
高分子流体和纳米复合材料的多尺度现象
- 批准号:
0308019 - 财政年份:2003
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
US-UAE Cooperative Research: Integrable Systems and Applications to Optical Pulse Propagation
美国-阿联酋合作研究:可积系统及其在光脉冲传播中的应用
- 批准号:
0096938 - 财政年份:2001
- 资助金额:
$ 20万 - 项目类别:
Standard Grant
相似国自然基金
IL17A在生物燃料烟雾致慢性阻塞性肺疾病粘液高分泌中的作用及机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于“肺主通调水道”理论研究补肺益肾方对慢阻肺模型大鼠钠离子通道和气道粘液纤毛功能障碍的影响
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
p62/SQSTM1通过Nrf2/ARE/HO-1途径抑制COPD气道粘液高分泌的作用及机制研究
- 批准号:82000042
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
MUC1对慢性阻塞性肺疾病气道粘液高分泌的调节作用及机制研究
- 批准号:81900033
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
香烟诱导3-磷酸肌醇依赖蛋白激酶1表达和气道粘液高分泌的分子机制研究
- 批准号:81870034
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
microRNA 200家族调控线粒体DAMPs释放介导香烟诱导气道炎症与黏液高分泌的机制研究
- 批准号:31871157
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
基于PI3K/Akt/NF-κB信号通路探讨运脾泻肺化痰方调控幼龄哮喘大鼠气道粘液高分泌的机制研究
- 批准号:81860868
- 批准年份:2018
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
Nanog在粘液型肺腺癌中的功能和机制研究
- 批准号:81802279
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
慢性阻塞性肺疾病中弹性蛋白多肽诱导粘液高分泌的作用及机制研究
- 批准号:81800033
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于粘液分泌机制探讨清肺化痰汤治疗COPD研究
- 批准号:81760744
- 批准年份:2017
- 资助金额:34.0 万元
- 项目类别:地区科学基金项目
相似海外基金
粘液産生性肺腺癌におけるmTOR/TFF-1の分子生物学的解析と新規バイオマーカーの確立
产生粘蛋白的肺腺癌中mTOR/TFF-1的分子生物学分析及新生物标志物的建立
- 批准号:
24K19438 - 财政年份:2024
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanistic triggers of excessive mucus during lung infections by bacterial volatile organic compounds
细菌挥发性有机化合物肺部感染期间粘液过多的机制触发因素
- 批准号:
10666271 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
浸潤性粘液性肺腺癌の進展機構の解明と新規治療標的の同定
阐明侵袭性粘液性肺腺癌的进展机制并确定新的治疗靶点
- 批准号:
22K15416 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Project 3: Membrane-bound mucins on the airway surface ensure efficient mucus clearance and lung health
项目 3:气道表面的膜结合粘蛋白确保有效的粘液清除和肺部健康
- 批准号:
10684209 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
Host microbiota and airway mucus: a novel paradigm for lung defense and immune homeostasis during early post-natal development
宿主微生物群和气道粘液:产后早期发育期间肺防御和免疫稳态的新范例
- 批准号:
10305691 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别:
Host microbiota and airway mucus: a novel paradigm for lung defense and immune homeostasis during early post-natal development
宿主微生物群和气道粘液:产后早期发育期间肺防御和免疫稳态的新范例
- 批准号:
10535465 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别:
浸潤性粘液腺癌の原因遺伝子解析研究
侵袭性粘液腺癌的基因分析研究
- 批准号:
20K16194 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Project 1: Mechanism of action of mucolytics in improving mucus clearance in lung disease
项目1:粘液溶解剂改善肺部疾病粘液清除的作用机制
- 批准号:
9356818 - 财政年份:2017
- 资助金额:
$ 20万 - 项目类别:
RNA Sequenceを用いた粘液性肺腺癌の解析
使用 RNA 序列分析粘液性肺腺癌
- 批准号:
17K08715 - 财政年份:2017
- 资助金额:
$ 20万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 1: Mechanism of action of mucolytics in improving mucus clearance in lung disease
项目1:粘液溶解剂改善肺部疾病粘液清除的作用机制
- 批准号:
10001598 - 财政年份:2017
- 资助金额:
$ 20万 - 项目类别: